Entity
Description
  • Value proposition

    Unlocking the potential of solid samples in the field of biological diagnostic

    Diagante develops a solution for in vitro diagnostics. Its platform allows the analysis of solid clinical specimen on rapid and high throughput instruments in clinical pathology labs. It provides faster results, enhanced personalized medical care, and lower costs to the stakeholders.

  • Original language

    Release the potential of solid biopsies

    Diagante develops preanalytical in vitro diagnostic medical devices that allows the preservation and the processing of solid samples. We enable rapid and high throughput diagnosis on all solid specimen, paving the way for next generation diagnostics.

    Diagante blurs the lines separating pathology and laboratory medicine, providing access to the analytical power of the instruments used to analyze biological fluids. Our mission is to disrupt the field of clinical pathology and positively impact the performance of diagnostic tests by improving the quality of all solid samples taken in the course of a surgery because valuable samples must be given the best attention. The right diagnostic is the easiest and cheapest way for better medical care.

    ---------------------------
    Diagante développe le dispositif médical TISSUtainer.

    La majorité des diagnostics de la médecine moderne sont basés sur la biologie médicale : tracer, éviter les erreurs diagnostiques tout en facilitant le travail des soignants permet de répondre aux enjeux de la médecine personnalisée et de l’efficience des soins.

    Plus spécifiquement, concernant les infections ostéo-articulaires, cette tendance est accentuée à la fois de fait de sa complexité mais également du fait d’un des plus grands succès de la médecine.

    Diagante, développe TISSUtainer, un dispositif médical qui permet à tous les patients de bénéficier du meilleur diagnostic au plus tôt.

  • Diagante

    Diagante is developing a medical device that allows all patients to benefit from the best and earliest diagnosis.

  • https://diagante.com/
Corporate interactions
Corporate TypeTweets Articles
Microsoft
Microsoft
IT services, Software Development
Microsoft
IT services, Software Development
Other

4 Mar 2025


France Biotech
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
France Biotech
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

6 Dec 2024


Groupe Hospitalier Diaconesses Croix Saint-Simon
Groupe Hospitalier Diaconesses Croix Saint-Simon
Health, Hospitals and Health Care
Groupe Hospitalier Diaconesses Croix Saint-Simon
Health, Hospitals and Health Care
Other

29 Nov 2024


WILCO
WILCO
Software Development
WILCO
Software Development
Other

26 Sep 2024


Greater Paris University Hospitals - AP-HP
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Greater Paris University Hospitals - AP-HP
Health, Hospitals and Health Care
Other

4 Mar 2025


BNP Paribas
BNP Paribas
Bank, Banking
BNP Paribas
Bank, Banking
Other

23 Sep 2024


CCI Paris
CCI Paris
Chamber of commerce, Government Administration
CCI Paris
Chamber of commerce, Government Administration
Other

5 Nov 2024


Le Catalyseur
Le Catalyseur
Government Administration
Le Catalyseur
Government Administration
Other

12 Mar 2025


Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration
Other

4 Jun 2024


Viva Technology
Viva Technology
Trade show, IT Services and IT Consulting
Viva Technology
Trade show, IT Services and IT Consulting
Other

22 May 2024


Similar entities
Loading...
Loading...
Social network dynamics